An interview with Dr Daniel Kraft about stage zero diagnosis
Today, medicine is reactive. But Dr Kraft is looking at how we can use data analysis for early diagnosis. Being able to respond to diseases sooner would give us more treatment options with more effective outcomes. “Stage Zero” diagnosis would change the way we experience disease.
Blood-based biomarkers and early eye patterns of dementia (see Neurotrack) could give us insights into Alzheimer's before the destructive plaques form. First, it will be a game of identifying the clinical demand and using tech to be smarter and more proactive.
“One thing that is a really stable element to look at is the power of Moore’s Law and other exponential technologies … it’s how computers are getting faster, cheaper and smaller and shrinking to the point that I can wear them on my wrist like my new Apple Watch or wear them soon under my skin or in neuro-implants to help people with everything from Parkinson’s [Disease] to Alzheimer’s [Disease]”.
Daniel Kraft at nuviun's Digital Health Live Conference
Technology is getting faster, smaller, more connected and more integrated. Our imagination can converge with our technical capacity to produce better solutions. The Star Trek Tricorder is becoming a reality.
Scanadu Scout just raised 35 million from crowdfunding for a trial, breaking a crowdfunding record. It’s a small device that you put on your forehead and it gives you data about your body.
Daniel Kraft is a Stanford- and Harvard- trained physician-scientist, inventor and innovator. He is faculty chair for Medicine at Singularity University and founding Executive Director and conference chairman for Exponential Medicine, exploring the impact and potential of rapidly developing technologies as applied to health and medicine. Kraft is also part of the elite circle of TED speakers.
An action driven man, Daniel Kraft loves to catalyse real change in medicine.